The Jinghua Pharmaceutical Group (002349.SZ) stated on the investor interaction platform on September 30 that the company and its subsidiaries are currently not engaged in CXO-related business.
精华制药(002349.SZ):公司及子公司目前未开展CXO相关业务
jinghua pharmaceutical group (002349.SZ): The company and its subsidiaries are currently not engaging in CXO related business.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.